Get started
Author

Vanessa A Marchant

Targeting inflammation to treat diabetic kidney disease: the road to 2030
2022 · Sandra Rayego-Mateos, Raul R Rodrigues-Diez, et al. · Kidney International · 371
RICORS2040: the need for collaborative research in chronic kidney disease
2021 · Alberto Ortiz, Marta Roger, et al. · Clinical Kidney Journal · 125
PDF
Statins: Could an old friend help in the fight against COVID‐19?
2020 · Raul R. Rodrigues‐Diez, Antonio Tejera‐Muñoz, et al. · British Journal of Pharmacology · 122
PDF
Role of Macrophages and Related Cytokines in Kidney Disease
2021 · Elena Cantero-Navarro, Sandra Rayego-Mateos, et al. · Frontiers in Medicine · 116
PDF
Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
2018 · Jose Luis Morgado-Pascual, Vanessa Marchant, et al. · Mediators of Inflammation · 73
PDF
Oxidative Stress and Cellular Senescence Are Involved in the Aging Kidney
2022 · Laura Marquez-Exposito, Lucia Tejedor-Santamaria, et al. · Antioxidants · 59
PDF
Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
2020 · Carolina Lavoz, Sandra Rayego-Mateos, et al. · Journal of Clinical Medicine · 48
PDF
Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy
2015 · Vanessa Marchant, Alejandra Droguett, et al. · American Journal of Physiology-Renal Physiology · 46
Acute Kidney Injury is Aggravated in Aged Mice by the Exacerbation of Proinflammatory Processes
2021 · Laura Marquez-Exposito, Lucia Tejedor-Santamaria, et al. · Frontiers in Pharmacology · 45
PDF
Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis
2023 · Flavia Trionfetti, Vanessa Marchant, et al. · International Journal of Molecular Sciences · 30
PDF
Interleukin-17A: Potential mediator and therapeutic target in hypertension
2021 · Raúl R. Rodrigues-Diez, Antonio Tejera-Muñoz, et al. · Nefrología (English Edition) · 22
PDF
IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis
2020 · Vanessa Marchant, Antonio Tejera-Muñoz, et al. · Biomolecules · 22
PDF
Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis
2022 · José Luis Morgado-Pascual, Beatriz Suarez-Alvarez, et al. · International Journal of Molecular Sciences · 18
PDF
Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis
2022 · Lucia Tejedor-Santamaria, Jose Luis Morgado-Pascual, et al. · Pharmaceuticals · 16
PDF
Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice
2022 · Lucas Opazo-Ríos, Antonio Tejera-Muñoz, et al. · Frontiers in Pharmacology · 15
Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión
2021 · Raúl R. Rodrigues-Diez, Antonio Tejera-Muñoz, et al. · Nefrología · 15
PDF
CCN2 Binds to Tubular Epithelial Cells in the Kidney
2022 · Sandra Rayego-Mateos, José Luis Morgado-Pascual, et al. · Biomolecules · 12
PDF
BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress
2023 · Vanessa Marchant, Flavia Trionfetti, et al. · Antioxidants · 9
PDF
Fast detection of Piscirickettsia salmonis in Salmo salar serum through MALDI‐TOF‐MS profiling
2016 · Verónica R. Olate, Fabiane M. Nachtigall, et al. · Journal of Mass Spectrometry · 8
Dasatinib and Quercetin Combination Increased Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy
2025 · Antonio Battaglia-Vieni, Vanessa Marchant, et al. · Pharmaceuticals · 7
STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis
2025 · Vanessa Marchant, Jorge García‐Giménez, et al. · The Journal of Pathology · 5
The Role of miR-802 in Diabetic Kidney Disease: Diagnostic and Therapeutic Insights
2025 · Antonio Tejera-Muñoz, Vanessa Marchant, et al. · International Journal of Molecular Sciences · 4
PDF
Ccn2 Deletion Reduces Cardiac Dysfunction, Oxidative Markers, and Fibrosis Induced by Doxorubicin Administration in Mice
2024 · Antonio Tejera-Muñoz, Marcelino Cortés, et al. · International Journal of Molecular Sciences · 4
PDF
Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype
2024 · Flavia Trionfetti, Claudia Montaldo, et al. · Frontiers in Cellular and Infection Microbiology · 4
Statins: Could an old friend help the fight against COVID-19?
2020 · Raúl Rodrigues Díez, Antonio Tejera-Muñoz, et al. · 3
PDF
Works count: 44
Citation count: 1,204
H-index: 15
I10-index: 17
Year
Topic
Type